Observational studySao Paulo medical journal = Revista paulista de medicina2026
Adverse reactions to etiological treatment in patients with Chagas disease in the Western Potiguar mesoregion of Brazil: a cross-sectional study.
Observational study in Sao Paulo medical journal = Revista paulista de medicina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChagas disease is a significant public health challenge in Brazil that is characterized by substantial morbidity and mortality rates, coupled with limited etiological treatment options.
objectiveTo describe and assess the occurrence of adverse reactions resulting from benznidazole treatment in patients from the Western Potiguar mesoregion of Brazil. DESIGN AND
settingThis retrospective, longitudinal, descriptive observational study included 106 individuals with Chagas disease who attended the Chagas Disease Outpatient Clinic of the Universidade do Estado do Rio Grande do Norte.
resultsAmong patients subjected to etiological treatment with benznidazole, 40.5% (43/106) experienced adverse reactions, manifesting in 13 distinct forms. The most prevalent reactions occurred primarily in the dermatological and hematological systems. Thus, despite the notable frequency of adverse reactions, their severity remained low, as evidenced by the minimal treatment suspension rate. The treatment demonstrated potential benefits to those affected by the disease.
conclusionsThis study characterized the most frequent adverse reactions to benznidazole, mainly dermatological and hematological reactions, which were mostly mild and rarely led to treatment suspension. Recognizing these events is essential for guiding professionals, enhancing patient confidence, and improving adherence to etiological treatments for Chagas disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.